RE:RE:FDA accepted & impending phase 3... Hand2hand, you win the silly drivel of the year award!
one item at a time.
first Roche has $53 billion in Revenue & in top ten of global pharma.
second Pfizer & previous stealing of patented etc Etc . Never happened. Even if it did why would they move ahead with a " well investigated agreement ( on both sides)"
Any company acquiring 10% of a company must disclose. So any silent takeover would soon be discovered & send share prices upwards.
Regarding preclinical deals being bought etc?
That has validity.
The key point is " doubt = discount".
recall 2018/19. There was a statement " lawyers are on vacation, when they return we hope for a deal".
There was an offer on the table, deemed totally unacceptable to Onc mangementement & BOD.
reasons? Not enough $$ and loss of corporate control & future direction of Pela.
Mangement feels Onc is worth more than a $Billion & has said so in the past.
When the 2018/19 events fell through, things took a major change.
Aware-1 was signed with one company & Bracelet with another.
Then , as time moved on the science ( via new technology & Aware-1) changed.
bringing into the fold, other opportunities.
Why has Onc not done a deal ( yet), because the requested studies , by the potential deal makers have not yet been completed.
Also....if you read the oncolytics biotech investor update on their web page.
They are not asking to be bought out. They are looking for liscensing partners.
Does not negate a takeover offer at any time.
problem?
Seeing a multi billion $$ potential, if Pela is proven as a co- therapy for any one of the major pharma, the price would be huge.
So, waiting for the Big payoff in the long run is apparently the road being taken.
if the science is there , the opportunities will come.
BTW, in 11 days there will be an additional update on the Gioblastoma trail, that in preliminary discussions said significant efficacy.
stay tuned.